comparemela.com

Page 7 - Nephrology Kidney Week News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Examining eGFR Slopes and Changes in Proteinuria in IgA Nephropathy, with Jonathan Barratt, MD

Joanthan Barratt, MD, discusses the results of a RaDaR analysis aimed at examining trends in time-averaged proteinuria and eGFR slope in patients with IgA nephropathy.

United statesUnited kingdomJonathan barrattAmerican society of nephrology kidney weekAlnylam pharmaceuticalsUnited kingdom kidney associationUniversity of leicesterAmerican societyNephrology kidney weekUnited kingdom national registryRare kidney diseasesMayer professorRenal medicineCalliditas therapeuticsTravere therapeuticsChinook therapeutics

Distance to Transplant Center Affects Follow-Up Care in Pediatric Transplant Recipients

Findings presented at ASN Kidney Week 2023 highlighted an association between distance to the transplant center and increased clinic cancellations.

United statesAmerican society of nephrology kidney weekAtrium health wake forest baptist medical centerWake forest school of medicineAmerican societyNephrology kidney weekSierra armstrongWake forest schoolFollow upPost transplant

Repeat Biopsy Analysis Underlines Safety, Efficacy of Voclosporin in Lupus Nephritis

An analysis of data from 26 patients with repeat kidney biopsies in the AURORA program suggests voclosporin (Lupkynis) reduces proteinuria without causing harm in lupus nephritis patients.

United statesSamirv parikhGreg keenanAmerican society of nephrology kidney weekDrug administrationAurinia pharmaceuticals incOhio state university wexner medical centerAmerican societyNephrology kidney weekOhio state university wexner medicalAurinia pharmaceuticalsAurinia pharmaceuticalLupus nephritisKidney weekKidney week 2023

Understanding ALCHEMIST Results, with Patrick Rossignol, MD, PhD

Patrick Rossignol, MD, PhD, provides additional perspective on the results of the ALCHEMIST trial from Kidney Week 2023.

United statesPatrick rossignolZannadf massyBoehringer ingelheimMonaco private haemodialysis centreDrug administrationAmerican society of nephrology kidney weekAmerican societyNephrology kidney weekPrincess grace hospitalKidney weekAntagonist chronicInterventional survival trialPaper presented

Early RUBY-3 Data Shows Promise for Povetacicept in Glomerulonephritis

Preliminary data from the open-label RUBY-3 trial were presented at the American Society of Nephrology Kidney Week 2023.

United statesEmory university school of medicineJames tumlinJonathan barrattAmerican society of nephrology kidney weekUniversity of leicesterAlpine immune sciencesNephronet clinical trials consortiumGeorgia nephrologyAmerican societyNephrology kidney weekEmory university schoolNephronet clinical trialsKidney weekImmune sciencesMayer professor

vimarsana © 2020. All Rights Reserved.